Metraipolis › archive › dc_bbae7df560eb

Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forward — Europe PMC PMID:42400688

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42400688
DOI: 10.1007/s10741-[numero omesso]-x
License (as archived): solo-consultazione
Archived: 2026-10-18T11:22:59.161Z
SHA-256 of the archived text: b72fddb91dc002218226497f78120778cff05ca246e069241138e5d5522f87eb
Stable URL of this page: https://metraipolis.com/documento/dc_bbae7df560eb

How to cite

Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forward — Europe PMC PMID:42400688 — Europe PMC (en), https://europepmc.org/article/MED/42400688 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbae7df560eb (Metraipolis archive dc_bbae7df560eb, sha256 b72fddb91dc002218226497f78120778cff05ca246e069241138e5d5522f87eb)

BibTeX

@misc{dcbbae7df560eb,
  title = {Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forward — Europe PMC PMID:42400688},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42400688},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbae7df560eb; sha256 b72fddb91dc002218226497f78120778cff05ca246e069241138e5d5522f87eb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42400688. Agents can read the archived copy with the MCP tool read_document.